Related Experiment Video
Updated: Jan 19, 2026

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
Published on: June 23, 2018
A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately
Huan Ouyang1, Zhuli Zheng, Yutong Chen
1Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Donghu District, Nanchang, 330006, China. drzwm@sina.com auyeungfoon1010@163.com.
A novel drug delivery platform using black phosphorus nanosheets (BP NSs) with iron oxide nanoparticles and polyethyleneimine (PEI) offers targeted, long-acting heparin delivery for effective thromboprophylaxis with reduced overdose risks.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Heparin is a crucial anticoagulant, but its short duration and overdose risks necessitate advanced delivery systems.
- Developing targeted and controlled drug release mechanisms is vital for improving anticoagulant therapy efficacy and safety.
Purpose of the Study:
- To develop a novel heparin-targeting delivery platform based on functionalized black phosphorus nanosheets (BP NSs).
- To evaluate the platform's heparin loading capacity, magnetic enrichment, biocompatibility, and in vivo therapeutic effects for thromboprophylaxis.
Main Methods:
- Fabrication of polyethyleneimine (PEI) functionalized black phosphorus nanosheets (BP NSs) integrated with iron oxide (Fe3O4) nanoparticles.
- In vitro and ex vivo assessment of heparin loading, magnetic targeting, and drug release kinetics.
- In vivo studies to evaluate the prolonged drug concentration, therapeutic efficacy, and safety of the PEI/Fe3O4@BP NSs platform.
Main Results:
- The PEI/Fe3O4@BP NSs platform demonstrated high heparin loading capacity (≈450%) and effective magnetic enrichment.
- Near-infrared (NIR) laser irradiation enhanced the photothermal thrombolysis effect.
- In vivo experiments confirmed prolonged effective heparin drug concentration, enabling accurate, long-acting thromboprophylaxis with reduced dosage.
Conclusions:
- The developed PEI/Fe3O4@BP NSs platform offers a promising approach for targeted, controlled, and long-acting heparin delivery.
- This innovative system significantly reduces the risks associated with heparin overdose, improving therapeutic outcomes in thromboprophylaxis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction

